New Delhi/UNI: Hours after the Drugs Controller General of India (DGCI) approved Oxford-AstraZeneca COVID-19 vaccine ''Covishield'' for restricted emergency use, Serum Institute of India (SII) CEO Adar Poonawalla announced that the vaccine is ready to roll out in the coming weeks.
New Delhi/IBNS: The Serum Institute of India (SII) has applied for an emergency approval from the Indian government of its vaccine against Covid-19, named Covishield.
New Delhi/IBNS: India, the second worst Covid-19-affected country in the world, reported over 48,000 new cases in the last 24 hours, taking the overall tally of infections to 80,88,851.
New Delhi/Pune/IBNS: Giving a hope to 1.3 billion people of India, vaccine manufacturer Serum Institute of India (SII)'s chief Adar Poonawalla has said the Oxford University's Covid-19 vaccine can be made available in the country by December 2020.
New Delhi: Serum Institute of India CEO Adar Poonawalla on Saturday asked whether the Indian government will have Rs. 80,000 crores over the next one year to buy and distribute the COVID-19 vaccine to everyone in India.
Pune: Adar Poonawalla, chief executive of the Serum Institute of India, has said it will take four to five years until everyone gets the COVID-19 vaccine on this planet.